Tokyo, Japan

Aiko Wada


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aiko Wada: Pioneering Innovations in Pharmaceutical Compounds

Introduction

Aiko Wada is a notable inventor based in Tokyo, Japan, recognized for her contributions to the field of pharmaceuticals. With a focus on developing innovative compounds, she holds a patent that showcases her expertise and creativity in medicinal chemistry.

Latest Patents

Wada's most recent patent involves a 2-cyanopyrrolidinecarboxamide compound, which includes a compound of the formula (I) or a pharmaceutically acceptable salt thereof. This invention represents a significant advancement in pharmaceutical formulations, potentially offering new avenues for medical treatment.

Career Highlights

Throughout her career, Aiko Wada has demonstrated a commitment to innovation in the pharmaceutical industry. She currently works at Astellas Pharma GmbH, where she collaborates with a team dedicated to bringing groundbreaking therapies to market. Her work emphasizes the importance of scientific research and development in improving health outcomes.

Collaborations

Wada is known for her collaborative spirit, having worked alongside esteemed colleagues Ichiro Shima and Akio Kuroda. Together, they combine their expertise and insights to drive forward the development of new pharmaceuticals, underscoring the value of teamwork in the pursuit of innovation.

Conclusion

Aiko Wada's patent reflects her dedication to advancing pharmaceutical science. As she continues her work at Astellas Pharma GmbH, her contributions are likely to influence both the industry and the health of individuals globally. Her journey exemplifies how innovative thinkers can make a substantial impact in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…